An investigation on behalf of investors in Obalon Therapeutics Inc (NASDAQ:OBLN) shares over potential wrongdoing at Obalon Therapeutics Inc was announced.
San Diego, CA -- (SBWIRE) -- 10/24/2018 -- An investigation was announced concerning possible breaches of fiduciary duties by certain directors at Obalon Therapeutics Inc.
Investors who purchased shares of Obalon Therapeutics Inc (NASDAQ:OBLN) and currently hold any of those NASDAQ:OBLN shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Obalon Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
On February 14, 2018, a lawsuit was filed against Obalon Therapeutics Inc (NASDAQ:OBLN) over alleged securities laws violations. The plaintiff alleged that the Defendants failed to disclose that Obalon Therapeutics Inc recognized revenue in violation of Generally Accepted Accounting principles ("GAAP"), that the Company lacked adequate internal controls over accounting and financial reporting, and that, as a result of the foregoing, Obalon Therapeutics Inc's financial statements and Defendants' statements about Obalon's business, operations, and prospects, were materially false and misleading at all relevant times.
Those who purchased shares of Obalon Therapeutics Inc (NASDAQ:OBLN), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels